Overall, Med+ members reached a 21% average weight loss at 12 months and maintained a 20.5% average weight loss at 24 months
Livak KJ, Schmittgen TD
Your doctor will consider factors like your current B12 levels, weight, age, and health goals
It triggers the release of insulin, which helps to regulate blood sugar levels, slow digestion and increase feelings of fullness.[1][2] These effects are why GLP-1-based medications (such as Mounjaro and Ozempic) have become so widely used in the management of type 2 diabetes and weight loss
We observed an increasing trend in Wegovy prescribing in the nondiabetic groups, with a significant jump in proportion among the nondiabetic obese/overweight group to 60% in 2023
January to May 2026 (In Progress): Remaining TRIUMPH Phase 3 trials (1, 2, and 3) are being completed